Response to upadacitinib in a patient with atopic dermatitis and HIV-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to upadacitinib in a patient with atopic dermatitis and HIV

Published:2024-07-19 Issue: Volume: Page:
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatology

Author:

Riquelme‐Mc Loughlin Constanza¹^ORCID,Sánchez‐Palomino Sonsoles²³,Blanco José L.²³

Affiliation:

1. Department of Dermatology Hospital Clínic de Barcelona, Universitat de Barcelona Barcelona Spain

2. HIV Unit. Hospital Clínic‐IDIBAPS, University of Barcelona Barcelona Spain

3. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC) Madrid Spain

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.17399

Reference5 articles.

1. Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis

2. HIV-1 gp120 Induces IL-4 and IL-13 Release from Human FcεRI+Cells Through Interaction with the VH3 Region of IgE

3. Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure

4. Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

5. The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP